Oct 22 2010
The oral direct thrombin inhibitor Dabigatran, (Boehringer-Ingelheim, Pradaxa®) was cleared Tuesday, October 19 for stroke prevention in atrial fibrillation. Dabigatran is the first of the new generation of oral anticoagulants to be released to the market. The press release from Boehringer is attached.
Comments (0)
Posts
No comments here.